Male Erectile Treatment Meds Articles News Glossary Site map
Index

Erectile dysfunction or "ED" is defined as the inability to obtain or maintain an erection sufficient for satisfactory sexual activity. It is the most widely studied disorder of male sexual function. Other less publicized disorders include: disorders of sexual desire, ejaculatory and orgasm disturbances, as well as disorders involving penile pain or curvature. ED is highly prevalent in the adult male population, and may effect as many as 50% of men between the ages of 40-70 years old.

In order to develop an erection, blood must be able to rapidly enter the male penis through two small arteries that course through the lower pelvis, just under the scrotum. The trigger for this blood flow event lies within the muscles that line the inside of the penis which relax involuntarily when there is sexual stimulation. Over the last 15 years a large amount of research has gone into defining the physiology of male erections. What has become clear is that for a man to develop a satisfactory erection there must be adequate blood flow, a well functioning nervous system, and a reasonable level of circulating male hormones such as testosterone. Diseases that affect any of these body systems can cause ED. In fact, population studies have confirmed that age, high blood pressure, diabetes, heart disease, cigarette smoking, excessive alcohol consumption, and low male hormone levels are significant risk factors for the development of ED. In addition, there are a large number of medications that are used to treat these disorders which may also cause ED.

Prior to the late 1990s, the only treatment available to men with ED were medications that could be injected directly into the penis, a vacuum canister that was applied to the outside of the penis and created an erection through suction, and surgical placement of a prosthetic device into the penis and scrotum. While these treatment options are still available, and provide very satisfactory results in many men with ED, they are not the first choice for the majority of men with ED. What was clearly needed was a pill that could be taken to improve erections.

Sexual dysfunction with hypothalamo-pituitary disorders

Decreased or absent sexual desire with erectile failure is a cardinal feature in males with hypothalamo-pituitary disorders., and is often the first symptom. However, the diagnosis is made only when other features appear, usually hypothyroidism or visual field defects. As many as 75 % of men with hypothalamo-pituitary disorders report decreased or absent sexual desire at the time of diagnosis. The figures are higher for those with larger tumours extending into the suprasellar region than for those with intrasellar tumours. A highly significant correlation has been found between low serum testosterone levels and a decrease in desire (Lundberg & Wide 1978). Decreased sexual desire is also the first symptom in most men with small pituitary tumours and hyperprolactinaemia (Muhr et al 1985); and these men often have low serum testosterone. In women, amenorrhoea and infertility are usually the presenting problems. In females aged 20-60 years with hypothalamo-pituitary disorders (Hulter & Lundberg 1994) two thirds noticed absent, or decreased sexual desire, especially when the serum prolactin was low. Problems with vaginal lubrication and orgasm are also very common in this group of women.
Although hypothalamo-pituitary disorder has many causes (Lundberg 1980), in a CT/MRI study of 164 impotent males with low serum testosterone values pathology in the hypothalamo-pituitary region was found only in 11 patients (Citron et al 1996). There are many rarer causes, however, including spinocerebellar ataxia (Neuhäuser & Opitz 1975, Berciano et al 1982, Koskinen et al 1995, Seminara et al 2002).

Related reading

Copyright © 2005-2012 Male Erectile Treatment Meds | All rights reserved.